Search by Drug Name or NDC
NDC 61919-0547-30 LOVASTATIN 20 mg/1 Details
LOVASTATIN 20 mg/1
LOVASTATIN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is LOVASTATIN.
MedlinePlus Drug Summary
Lovastatin is used together with diet, weight-loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. Lovastatin is also used to decrease the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. Lovastatin is in a class of medications called HMG CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats with lovastatin may help prevent heart disease, angina (chest pain), strokes, and heart attacks.
Related Packages: 61919-0547-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lovastatin
Product Information
| NDC | 61919-0547 |
|---|---|
| Product ID | 61919-547_fb484a4b-46c5-39ed-e053-6294a90ad216 |
| Associated GPIs | 39400050000310 |
| GCN Sequence Number | 006460 |
| GCN Sequence Number Description | lovastatin TABLET 20 MG ORAL |
| HIC3 | M4D |
| HIC3 Description | ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS) |
| GCN | 47040 |
| HICL Sequence Number | 002793 |
| HICL Sequence Number Description | LOVASTATIN |
| Brand/Generic | Generic |
| Proprietary Name | LOVASTATIN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LOVASTATIN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | LOVASTATIN |
| Labeler Name | Direct_Rx |
| Pharmaceutical Class | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075991 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0547-30 (61919054730)
| NDC Package Code | 61919-547-30 |
|---|---|
| Billing NDC | 61919054730 |
| Package | 30 TABLET in 1 BOTTLE (61919-547-30) |
| Marketing Start Date | 2014-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |